REGENERON PHARMACEUTICALS (REGN) Stock Balance Sheet
NASDAQ:REGN • US75886F1075
Current stock price
736.53 USD
+3.66 (+0.5%)
At close:
736.53 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 18.87B | 2.49B | 2.73B | 3.11B | 2.89B | |||
| Marketable Securities | 5.49B | 6.52B | 8.11B | 4.64B | 2.81B | |||
| Receivables | 5.74B | 6.21B | 5.67B | 5.33B | 6.04B | |||
| Inventories | 2.47B | 3.09B | 2.58B | 2.40B | 1.95B | |||
| Other Current Assets | 1.20B | 349.20M | 386.60M | 411.20M | 332.40M | |||
| Total Current Assets | 18.02B | 18.66B | 19.48B | 15.88B | 14.01B | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.37B | 4.82B | 4.22B | 3.76B | 3.48B | |||
| Investments And Advances | 10.59B | 9.06B | 5.47B | 6.64B | 6.88B | |||
| Intangibles | 1.26B | 1.15B | 1.04B | 915.50M | N/A | |||
| Other Non-Current Assets | 5.32B | 4.07B | 2.87B | 2.01B | 1.06B | |||
| Total Non-Current Assets | 22.54B | 19.10B | 13.60B | 13.33B | 11.42B | |||
| TOTAL ASSETS | 40.56B | 37.76B | 33.08B | 29.21B | 25.43B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 719.70M | |||
| Accrued Expenses | 2.53B | 2.31B | 2.36B | 2.07B | 1.88B | |||
| Accounts Payable | 6.77B | 789.50M | 606.60M | 589.20M | 564.00M | |||
| Other Current Liabilities | 904.30M | 840.90M | 458.90M | 478.20M | 768.30M | |||
| Total Current Liabilities | 4.37B | 3.94B | 3.42B | 3.14B | 3.93B | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.71B | 2.70B | 2.70B | 2.70B | 1.98B | |||
| Other Non-Current Liabilities | 2.23B | 1.76B | 980.80M | 707.80M | 753.50M | |||
| Total Non-Current Liabilities | 4.93B | 4.46B | 3.68B | 3.41B | 2.73B | |||
| TOTAL LIABILITIES | 9.30B | 8.41B | 7.11B | 6.55B | 6.67B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 35.80B | 31.67B | 27.26B | 23.31B | 18.97B | |||
| Additional Paid In Capital | 13.99B | 12.86B | 11.35B | 9.95B | 8.09B | |||
| Common Shares | 101.80K | 102.00K | 102.00K | 100.00K | 100.00K | |||
| Treasury Stock | -18.61B | -15.17B | -12.56B | -10.35B | -8.26B | |||
| Other Shareholders' Equity | 77.50M | -7.90M | -80.90M | -238.80M | -26.20M | |||
| Shares Outstanding | 105.70M | 109.60M | 109.40M | 109.60M | 108.67M | |||
| Tangible Book Value per Share | 283.82 | 257.34 | 227.92 | 198.44 | 172.71 | |||
| Total Shareholders' Equity | 31.26B | 29.35B | 25.97B | 22.66B | 18.77B | |||
| TOTAL LIABILITIES AND EQUITY | 40.56B | 37.76B | 33.08B | 29.21B | 25.43B | |||
| Statistics | ||||||||
| Debt/Equity | 0.09 | 0.09 | 0.10 | 0.12 | 0.11 | |||
| Current Ratio | 4.13 | 4.73 | 5.69 | 5.06 | 3.56 | |||
| Return On Assets (ROA) | 11.11% | 11.69% | 11.95% | 14.85% | 31.75% | |||
| Return On Equity (ROE) | 14.41% | 15.03% | 15.22% | 19.14% | 43.03% | |||
| Return On Invested Capital (ROIC) | 9.60% | 11.18% | 13.11% | 18.06% | 38.45% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 29.34% | 15.25% | 20.66% | 25.69% | 52.30% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 32.83% | 15.99% | 21.87% | 27.04% | 52.30% | |||
All data in USD , ROIC based on taxRate of 0.10